457 results found

Significant changes to Ireland’s merger control regime at the end of last year have already had an impact on the number and type of transactions being notified to the new Competition and Consumer Protection Commission.

A leading Irish law firm's Competition and Regulated Markets Group provides comprehensive merger control advisory services, handling complex cases before the Competition and Consumer Protection Commission (CCPC) and European Commission. The team also navigates Ireland's foreign direct investment screening regime, assisting international investors and Irish businesses with national security and public order considerations in cross-border transactions.

The lowering of the Irish merger control thresholds towards the back end of 2014 prompted a significant uptick in the number of merger filings in 2015 (78 in total).

One of the most immediate impacts of COVID-19 will be on the potential increased scope of the due diligence process.

The Companies Act 2014 (Commencement) Order 2015 (S.I. 169 of 2015) was signed by the Minister for Jobs, Enterprise and Innovation, Richard Bruton TD, on 1 May 2015.

The Companies (Corporate Governance, Enforcement and Regulatory Provisions) Act 2024 was signed into law on 12 November and amends the Companies Act 2014 (the Act).

M&A activity in Ireland has been consistently dominated by mid-market transactions and 2022 was no exception: almost nine in ten Irish M&A deals last year fell into the mid-market segment...

The Minister for Business, Enterprise and Innovation, Heather Humphries, has laid the Competition Act 2002 (Section 27) Order 2018 (the "Order") before the Houses of the Oireachtais on 3 October 2018

Overseas investors remain committed to Ireland: foreign acquirers conducted 216 transactions in the country in 2022 – one more than in 2021, but the total value of inbound deals fell by almost a third to €12.5bn.

It is expected that turnover thresholds which determine whether mergers and acquisitions are required to be notified to the Competition and Consumer Protection Commission in Ireland ("CCPC") will increase in line with the table below with effect from 1 January 2019.

Matheson continues to advise Royalty Pharma on its $6.5 billion cash offer for Elan Corporation plc, the Irish biotechnology company.

We recently came across a situation which highlighted the importance of including a no-agency boilerplate provision ...

By way of correspondence dated 9 October 2018 to Irish Funds, the trade body representing funds established in Ireland, the Central Bank of Ireland (the "Central Bank") ...

Recognising the demand among fund managers to utilise a regulated partnership vehicle, a number of important enhancements have recently been made to the Irish Investment Limited Partnership vehicle through the enactment ...

With unrivalled experience of advising clients who operate in the Food and Beverage sector, both here in Ireland and internationally, Matheson is leading the way in Ireland's largest indigenous sector.

Ireland continues to be an attractive draw for private equity with a number of material transactions taking place so far in 2024, but firms are more deliberate in their dealmaking.

Inbound activity is reduced YoY, in line with the overall market, but still accounts for almost over two-thirds of Irish M&A deals in H1 2023 – 113 of the total 177...